Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 29
1990 19
1991 55
1992 107
1993 139
1994 131
1995 157
1996 145
1997 156
1998 165
1999 166
2000 152
2001 187
2002 139
2003 108
2004 127
2005 112
2006 114
2007 87
2008 79
2009 78
2010 81
2011 81
2012 101
2013 108
2014 76
2015 76
2016 99
2017 75
2018 76
2019 63
2020 74
2021 77
2022 64
2023 59
2024 44

Text availability

Article attribute

Article type

Publication date

Search Results

3,402 results

Results by year

Filters applied: . Clear all
Page 1
Status migrainosus.
Kamourieh S, Rozen T, Anderson JM. Kamourieh S, et al. Handb Clin Neurol. 2024;199:413-439. doi: 10.1016/B978-0-12-823357-3.00017-3. Handb Clin Neurol. 2024. PMID: 38307660 Review.
Given the severity and need for emergency care, options detailed are in line with recommendations for acute migraine care: with a staged approach initially combining subcutaneous sumatriptan with parenteral options including dopamine receptor antagonists, nonsteroidal anti …
Given the severity and need for emergency care, options detailed are in line with recommendations for acute migraine care: with a staged app …
Headache recurrence.
Pfaffenrath V. Pfaffenrath V. Cephalalgia. 1996 Jun;16(4):215-6. doi: 10.1046/j.1468-2982.1996.1604215-4.x. Cephalalgia. 1996. PMID: 8792028 No abstract available.
Migraine.
Ferrari MD. Ferrari MD. Lancet. 1998 Apr 4;351(9108):1043-51. doi: 10.1016/S0140-6736(97)11370-8. Lancet. 1998. PMID: 9546526 Review. No abstract available.
Sumatriptan.
Kaube H, May A, Pfaffenrath V. Kaube H, et al. BMJ. 1994 Jun 11;308(6943):1573-4. doi: 10.1136/bmj.308.6943.1573d. BMJ. 1994. PMID: 8019338 Free PMC article. Clinical Trial. No abstract available.
Sumatriptan/Naproxen Sodium: A Review in Migraine.
Syed YY. Syed YY. Drugs. 2016 Jan;76(1):111-21. doi: 10.1007/s40265-015-0521-8. Drugs. 2016. PMID: 26628293 Review.
Sumatriptan/naproxen sodium (Treximet) is a fixed-dose combination of a serotonin 5-HT1B/1D receptor agonist (sumatriptan) and an NSAID (naproxen sodium), approved in the USA for the acute treatment of migraine with or without aura in adolescents and adults. ...S …
Sumatriptan/naproxen sodium (Treximet) is a fixed-dose combination of a serotonin 5-HT1B/1D receptor agonist (sumatriptan) and …
Sumatriptan clinical pharmacokinetics.
Scott AK. Scott AK. Clin Pharmacokinet. 1994 Nov;27(5):337-44. doi: 10.2165/00003088-199427050-00002. Clin Pharmacokinet. 1994. PMID: 7851052 Review.
Sumatriptan is a novel serotonin 1 (5-hydroxytryptamine 1; 5-HT1)-like agonist which has been shown to be effective in the treatment of acute migraine. ...No significant interaction was found between sumatriptan and propranolol, flunarizine, pizotifen or alcohol (et …
Sumatriptan is a novel serotonin 1 (5-hydroxytryptamine 1; 5-HT1)-like agonist which has been shown to be effective in the treatment …
Sumatriptan-naproxen sodium in migraine: A review.
Wilcha RJ, Afridi SK, Barbanti P, Diener HC, Jürgens TP, Lanteri-Minet M, Lucas C, Mawet J, Moisset X, Russo A, Sacco S, Sinclair AJ, Sumelahti ML, Tassorelli C, Goadsby PJ. Wilcha RJ, et al. Eur J Neurol. 2024 Sep;31 Suppl 2(Suppl 2):e16434. doi: 10.1111/ene.16434. Eur J Neurol. 2024. PMID: 39318200 Free PMC article. Review.
BACKGROUND: Varied responses to acute migraine medications have been observed, with over one-third (34.5%) of patients reporting insufficient headache relief. Sumatriptan-naproxen sodium, a single, fixed-dose combination tablet comprising sumatriptan 85 mg and napro …
BACKGROUND: Varied responses to acute migraine medications have been observed, with over one-third (34.5%) of patients reporting insufficien …
Imitrex.
Stewart S, Gorman DG. Stewart S, et al. Cephalalgia. 1998 Oct;18(8):588. doi: 10.1046/j.1468-2982.1998.18085853.x. Cephalalgia. 1998. PMID: 9827255 No abstract available.
Sumatriptan as a First-Line Treatment for Headache in the Pediatric Emergency Department.
Hauser Chatterjee J, Hartford EA, Law E, Barry D, Blume H. Hauser Chatterjee J, et al. Pediatr Neurol. 2023 May;142:68-75. doi: 10.1016/j.pediatrneurol.2023.01.016. Epub 2023 Feb 4. Pediatr Neurol. 2023. PMID: 36958085 Review.
Forty-eight percent of patients received IN sumatriptan in the ED, and 36% of those who received sumatriptan were prescribed oral sumatriptan at discharge. ...Further research is needed to determine the efficacy of IN sumatriptan relative to other comm …
Forty-eight percent of patients received IN sumatriptan in the ED, and 36% of those who received sumatriptan were prescribed o …
Beyond its anti-migraine properties, sumatriptan is an anti-inflammatory agent: A systematic review.
Ala M, Ghasemi M, Mohammad Jafari R, Dehpour AR. Ala M, et al. Drug Dev Res. 2021 Nov;82(7):896-906. doi: 10.1002/ddr.21819. Epub 2021 Apr 1. Drug Dev Res. 2021. PMID: 33792938 Review.
Sumatriptan is the first available medication from triptans family that was approved by the U.S. ...Considering the safety and potency of low dose sumatriptan compared to corticosteroids and other immunosuppressive medications, it is worth to take advantage of su …
Sumatriptan is the first available medication from triptans family that was approved by the U.S. ...Considering the safety and potenc …
3,402 results